Friday 6 November 2026
Export DOCS’s income statement to Excel — free account
Doximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
32.10
1.08
−3.25%
Follow DOCS
Alert me
Doximity, Inc. (DOCS) SEC filings, changes and red flags
Red flags
-
Receivables outpacing revenue
Receivables grew 28.5% while revenue grew 3.6% year over year
-
Officer departure
Doximity, Inc. reported the departure of an officer or director
Filings
| Form | Period | Filed | What it reports | Flags |
|---|---|---|---|---|
| 10-Q | Sep 30, 2026 |
P1I2: 7 added · 24 modified P2I1A: no material changes, the filing says |
Receivables outpacing revenue | |
| 8-K | Nov 5, 2026 | 2.02 Results of operations and financial condition | ||
| 8-K | Aug 27, 2026 | 5.07 Submission of matters to a vote of security holders | ||
| 10-Q | Jun 30, 2026 |
P1I2: 5 added · 7 removed · 38 modified P2I1A: no material changes, the filing says |
||
| 8-K | Aug 6, 2026 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-K | Mar 31, 2026 |
1: 9 added · 4 removed · 31 modified 1A: 15 added · 75 modified 7: 10 added · 6 removed · 28 modified |
||
| 8-K | May 13, 2026 | 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | Officer departure | |
| 8-K | Apr 13, 2026 | 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure | ||
| 10-Q | Dec 31, 2025 | |||
| 8-K | Feb 3, 2026 | 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits | ||
| 8-K | Dec 24, 2025 | 8.01 Other events | ||
| 10-Q | Sep 30, 2025 | |||
| 8-K | Nov 6, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Aug 28, 2025 | 5.07 Submission of matters to a vote of security holders | ||
| 10-Q | Jun 30, 2025 | |||
| 8-K | Aug 7, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-K | Mar 31, 2025 | |||
| 8-K | May 15, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Dec 31, 2024 | |||
| 8-K | Feb 6, 2025 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Sep 30, 2024 | |||
| 8-K | Nov 7, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 10-Q | Jun 30, 2024 | |||
| 8-K | Aug 8, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | May 16, 2024 | 2.02 Results of operations and financial condition; 7.01 Regulation FD disclosure | ||
| 8-K | Feb 8, 2024 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits | ||
| 8-K | Nov 9, 2023 | 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits |